ENA Respiratory Wins USPTO Patents for TLR2 Innate Immune Modulators
The allowances cover both composition-of-matter and method-of-use claims, strengthening IP position in the emerging inn…
The allowances cover both composition-of-matter and method-of-use claims, strengthening IP position in the emerging inn…
Functional News covers ingredients, finished formulations, clinical nutrition, and supplement regulation — not hospital…
The Amsterdam showcase signals growing operator appetite for workflow-integrated AI diagnostics — a trend with downstre…
The MHRA approval expands emergency allergy management options for a pediatric population where needle-based delivery h…
Microbiome-mimicry immunotherapy edges toward clinical validation — with implications for how gut-derived peptides may …
As precision oncology expands BTK-inhibitor research, ingredient developers tracking immune-pathway mechanisms are watc…
Data from Stockholm congress covers two China-approved oncology assets with implications for global development pipelin…
Celldex's anti-KIT monoclonal antibody moves the goalposts from symptom control to potential disease modification — a s…
Late-breaking findings presented at the Endocrine Society Annual Meeting add cardiovascular biomarker evidence to the a…
The EAACI 2026 responder analysis adds to mounting evidence for targeted biologics in upper-airway inflammatory conditi…
The coalition push highlights growing intersections between blood health, iron status nutrition, and functional supplem…
The submitted release covers hospital AI strategy, not functional ingredients, nutraceuticals, or dietary supplements —…